Clinicopathological risk factors such as KPS, gender, age, IDH status and O6-methylguanine-DNA methyltransferase (MGMT) have been the most utilized factors used to construct survival nomograms of GBM patients in previous studies. Here, MGMT is linked to glioblastoma.